← Every company
Oramed Pharmaceuticals Inc SEC Filings
What Oramed Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
ORMP overview →Filings on file
104
since Nov 25, 2016
Warning signs
1
latest May 15, 2026
Last results
Nov 17, 2025
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Sep 17, 2026 | Shareholder vote 8-K | Read ↗ |
| Aug 10, 2026 | Quarterly report 10-Q | Read ↗ |
| May 19, 2026 | Quarterly report 10-Q | Read ↗ |
| May 15, 2026 | Late filing notice NT 10-Q | Read ↗ |
| Mar 31, 2026 | Acquisition or sale completedMaterial agreement 8-K | Read ↗ |
| Mar 26, 2026 | Annual report 10-K | Read ↗ |
| Feb 20, 2026 | Material agreement 8-K | Read ↗ |
| Jan 14, 2026 | Material agreement 8-K | Read ↗ |
| Dec 31, 2025 | Executive or director change 8-K | Read ↗ |
| Nov 17, 2025 | Results announced 8-K | Read ↗ |
| Nov 17, 2025 | Material agreement 8-K | Read ↗ |
| Nov 13, 2025 | Quarterly report 10-Q | Read ↗ |
| Oct 24, 2025 | Results announcedMaterial agreement 8-K | Read ↗ |
| Aug 21, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Aug 14, 2025 | Quarterly report 10-Q | Read ↗ |
| Jul 23, 2025 | Material agreement 8-K | Read ↗ |
| Jul 16, 2025 | Annual report 10-K/A | Read ↗ |
| May 15, 2025 | Quarterly report 10-Q | Read ↗ |
| Apr 28, 2025 | Material agreement 8-K | Read ↗ |
| Mar 27, 2025 | Annual report 10-K | Read ↗ |
| Mar 3, 2025 | Material agreement 8-K | Read ↗ |
| Feb 27, 2025 | Material agreement 8-K | Read ↗ |
| Feb 11, 2025 | Material agreement 8-K | Read ↗ |
| Jan 22, 2025 | Material agreement 8-K | Read ↗ |
| Jan 3, 2025 | Material agreement 8-K | Read ↗ |
| Nov 7, 2024 | Quarterly report 10-Q | Read ↗ |
| Oct 8, 2024 | Material agreement 8-K | Read ↗ |
| Sep 26, 2024 | Material agreement 8-K | Read ↗ |
| Aug 14, 2024 | Quarterly report 10-Q | Read ↗ |
| Aug 2, 2024 | Shareholder vote 8-K | Read ↗ |
| Jun 10, 2024 | Executive or director change 8-K | Read ↗ |
| May 13, 2024 | Executive or director change 8-K | Read ↗ |
| May 9, 2024 | Quarterly report 10-Q | Read ↗ |
| Mar 18, 2024 | Executive or director change 8-K | Read ↗ |
| Mar 18, 2024 | Material agreement 8-K | Read ↗ |
| Mar 6, 2024 | Annual report 10-K | Read ↗ |
| Jan 23, 2024 | Material agreement 8-K | Read ↗ |
| Jan 19, 2024 | Executive or director change 8-K | Read ↗ |
| Dec 18, 2023 | Executive or director change 8-K | Read ↗ |
| Nov 9, 2023 | Quarterly report 10-Q | Read ↗ |
| Sep 26, 2023 | Material agreement 8-K | Read ↗ |
| Aug 22, 2023 | Material agreement 8-K | Read ↗ |
| Aug 10, 2023 | Quarterly report 10-Q | Read ↗ |
| Aug 9, 2023 | Material agreement 8-K | Read ↗ |
| Jul 13, 2023 | Shareholder vote 8-K | Read ↗ |
| May 11, 2023 | Quarterly report 10-Q | Read ↗ |
| May 1, 2023 | Executive or director change 8-K | Read ↗ |
| Mar 6, 2023 | Annual report 10-K | Read ↗ |
| Nov 10, 2022 | Results announced 8-K | Read ↗ |
| Nov 10, 2022 | Quarterly report 10-Q | Read ↗ |
| Aug 10, 2022 | Quarterly report 10-Q | Read ↗ |
| Jun 30, 2022 | Shareholder vote 8-K | Read ↗ |
| May 12, 2022 | Quarterly report 10-Q | Read ↗ |
| Apr 4, 2022 | Executive or director change 8-K | Read ↗ |
| Jan 11, 2022 | Quarterly report 10-Q | Read ↗ |
| Nov 24, 2021 | Annual report 10-K | Read ↗ |
| Nov 4, 2021 | Material agreement 8-K | Read ↗ |
| Sep 1, 2021 | Material agreement 8-K | Read ↗ |
| Aug 31, 2021 | Shareholder vote 8-K | Read ↗ |
| Jul 15, 2021 | Material agreement 8-K | Read ↗ |
| Jul 14, 2021 | Quarterly report 10-Q | Read ↗ |
| Jun 16, 2021 | Material agreement 8-K | Read ↗ |
| May 25, 2021 | Executive or director change 8-K | Read ↗ |
| May 10, 2021 | Executive or director change 8-K | Read ↗ |
| Apr 13, 2021 | Quarterly report 10-Q | Read ↗ |
| Mar 19, 2021 | Material agreement 8-K | Read ↗ |
| Jan 14, 2021 | Quarterly report 10-Q | Read ↗ |
| Dec 1, 2020 | Material agreement 8-K | Read ↗ |
| Nov 24, 2020 | Annual report 10-K | Read ↗ |
| Sep 18, 2020 | Material agreement 8-K | Read ↗ |
| Sep 9, 2020 | Material agreement 8-K | Read ↗ |
| Aug 27, 2020 | Material agreement 8-K | Read ↗ |
| Aug 4, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jul 7, 2020 | Quarterly report 10-Q | Read ↗ |
| Apr 6, 2020 | Quarterly report 10-Q | Read ↗ |
| Feb 28, 2020 | Material agreement 8-K | Read ↗ |
| Jan 9, 2020 | Quarterly report 10-Q | Read ↗ |
| Dec 6, 2019 | Executive or director change 8-K | Read ↗ |
| Nov 27, 2019 | Annual report 10-K | Read ↗ |
| Sep 5, 2019 | Executive or director changeMaterial agreementShareholder vote 8-K | Read ↗ |
| Aug 21, 2019 | Executive or director change 8-K | Read ↗ |
| Jul 29, 2019 | Executive or director change 8-K | Read ↗ |
| Jul 10, 2019 | Quarterly report 10-Q | Read ↗ |
| Jul 1, 2019 | Executive or director change 8-K | Read ↗ |
| May 16, 2019 | Executive or director change 8-K | Read ↗ |
| Apr 16, 2019 | Material agreement 8-K | Read ↗ |
| Apr 10, 2019 | Quarterly report 10-Q | Read ↗ |
| Mar 28, 2019 | Executive or director change 8-K | Read ↗ |
| Jan 14, 2019 | Quarterly report 10-Q | Read ↗ |
| Nov 28, 2018 | Annual report 10-K | Read ↗ |
| Nov 8, 2018 | Executive or director change 8-K | Read ↗ |
| Aug 30, 2018 | Shareholder vote 8-K | Read ↗ |
| Jul 12, 2018 | Quarterly report 10-Q | Read ↗ |
| Jul 5, 2018 | Material agreement 8-K | Read ↗ |
| Apr 9, 2018 | Quarterly report 10-Q | Read ↗ |
| Feb 20, 2018 | Material agreement 8-K | Read ↗ |
| Jan 11, 2018 | Quarterly report 10-Q | Read ↗ |
| Nov 29, 2017 | Annual report 10-K | Read ↗ |
| Sep 5, 2017 | Shareholder vote 8-K | Read ↗ |
| Jul 21, 2017 | Executive or director change 8-K | Read ↗ |
| Jul 6, 2017 | Quarterly report 10-Q | Read ↗ |
| Apr 5, 2017 | Quarterly report 10-Q | Read ↗ |
| Jan 11, 2017 | Quarterly report 10-Q | Read ↗ |
| Nov 25, 2016 | Annual report 10-K | Read ↗ |
Source: Oramed Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on ORMP
Company overviewEverything on ORMP in one place, with the price.Insider tradingWhat ORMP's own officers and directors buy and sell.Executive payWhat ORMP awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in ORMP.Funds holding itWhich funds and ETFs hold ORMP, and how big a bet.PatentsWhat ORMP is filing at the patent office.